Fibrinogenase is a type of enzyme that specifically cleaves the protein fibrinogen, which is a key component of blood clotting. This enzyme plays a critical role in the breakdown of fibrinogen into fibrin, which ultimately leads to the formation of blood clots. Research in this area focuses on understanding the mechanisms of fibrinogenase action, its role in blood coagulation, and its potential applications in the treatment of blood clotting disorders. Additionally, studies on fibrinogenase inhibitors are also being conducted to explore potential therapeutic interventions for conditions characterized by abnormal blood clotting.